Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin plus weekly paclitaxel for advanced squamous lung cancer with idiopathic interstitial pneumonia
jRCTs051180149Phase 2Completed
- Sponsor
- Kobe City Medical Center General Hospital
- Start
- Jan 2013
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carboplatin and paclitaxel in Pulmonary squamous cell carcinoma and idiopathic interstitial pneumonia (IIP), sponsored by Kobe City Medical Center General Hospital. Primary endpoint: Response rate. Started Jan 2013; status: completed.
02
Drugs
carboplatinpaclitaxel
03
Conditions
Pulmonary squamous cell carcinomaidiopathic interstitial pneumonia (IIP)
Beyond the preview
Go deeper on jRCTs051180149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180149.